Search Results
297 items found for "P2Y receptor"
- Aberrant hormone receptors regulate a wide spectrum of endocrine tumors
< GPCR News < GPCRs in Oncology and Immunology Aberrant hormone receptors regulate a wide spectrum of endocrine tumors Published date September 23, 2024 Abstract "Aberrant G-protein coupled receptor (GPCR somatotroph tumours; AVPR2, D2DR, and SSTR5 in pituitary corticotroph tumours; GLP1R, GIPR, and somatostatin receptors
- The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor
< GPCR News < GPCRs in Oncology and Immunology The orphan G protein-coupled receptor 141 expressed in cells functions as an inflammation suppressor Published date April 29, 2024 Abstract "G protein-coupled receptors Here, we demonstrate that GPR141, an orphan GPCR belonging to the class A receptor family, suppresses Authors Atsuya Sawabe, Shogo Okazaki, Akira Nakamura, Ryo Goitsuka, Tomonori Kaifu Tags G protein–coupled receptor
- Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes
Analysis of their Conformational Landscapes Published date June 20, 2024 Abstract "The canonical chemokine receptor CXCR4 and atypical receptor ACKR3 both respond to CXCL12 but induce different effector responses to The receptors also have distinct activation requirements. of CXCR4 and ACKR3, we employed single-molecule FRET to track discrete conformational states of the receptors This and the markedly different conformational landscapes of the receptors suggest that activation of
- GPCR Retreat 2023 - Part I
With respect to GPCRs, I'm particularly interested in peptide/small protein receptors and the mechanisms With a special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular motivated behavior and how these receptors can be targeted for therapeutic benefit. These ligands stimulate receptor β-arrestin recruitment without activating canonical G protein signaling Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor
- Ep 87 with Dr. Bianca Plouffe
same university in 2005 by investigating the molecular mechanisms involved in the angiotensin type 2 receptor She identified the molecular mechanisms involved in the opposite regulation of dopamine D1 and D5 receptors She identified the structural determinant controlling biased signaling of melatonin type 2 receptors Award, she investigated biased and compartmentalized G protein signaling by the vasopressin type 2 receptor understanding the role of compartmentalized Gq signaling by the cytomegalovirus-encoded chemokine US28 receptor
- Enterococcus-derived tyramine hijacks α2A-adrenergic receptor in intestinal stem cells to exacerbate colitis
< GPCR News < GPCRs in Oncology and Immunology Enterococcus-derived tyramine hijacks α2A-adrenergic receptor Here, we identify α2A-adrenergic receptor (ADRA2A) as a highly expressed GPCR in ISCs. Enterococcus , IBD , ISCs , colitis , inflammatory bowel disease , tyramine , yohimbine , α(2A)-adrenergic receptor
- Trainee Symposium II
Symposium II Date & Time Thursday, November 2nd / 3:00 PM - 4:00 PM Title: Linking Proteinase Activated Receptor Medicine and Dentistry, Western University, researching the molecular mechanisms of Proteinase-Activated Receptors GPCR Title: Balancing G Protein Selectivity and Efficacy in the Adenosine A2A Receptor About Louis-Philippe GPCR Title: Antibodies Expand the Scope of Angiotensin Receptor Pharmacology About Meredith Skiba "Meredith pharmacology, and structural biology to study how different types of ligands modulate angiotensin receptor
- LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration
signaling and cell migration Published date September 25, 2023 Abstract "Background: G protein-coupled receptor CXC chemokine receptor 4 (CXCR4) and its ligand CXCL12, both of which are overexpressed in many cancers Likewise, lysophosphatidic acid receptor 1 (LPA1) is implicated in cancer cell proliferation and migration 4 , Chemotaxis , G protein-coupled receptor , GPCR heteromer , GPCR signaling , Inflammatory disease , Lysophosphatidic acid receptor 1 Source Contribute to the GPCR News Coming soon Become a Contributor
- Ep 83 with Dr. Jean-Philippe Pin
Jean-Philippe Pin Jean-Philippe Pin participated in the discovery of metabotropic glutamate receptors been studying the allosteric modulation and activation mechanism of this family of G protein-coupled receptors His studies led to new concepts in the GPCR field, such as the activation of cell surface receptors by
- Ep 42 with Dr. Randy Hall
graduate school at the University of California at Irvine, studying the regulation of ionotropic glutamate receptors , Oregon, to do a post-doctoral fellowship in the laboratory of Thomas Soderling studying glutamate receptor continued his post-doctoral training at Duke University, where he studied the regulation of adrenergic receptors contributions to understanding the signaling, regulation and in vivo actions of the neuroprotective receptors Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb receptor
- Ep 02 with Dr. Terry Hébert
Today he and his team are working on understanding receptor signaling in specialized cellular environments to gain a better grasp of receptor function in pathophysiological settings with a special interest in His favorite GPCR is the angiotensin 1 receptor, especially for its ability to activate a large variety
- Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
< GPCR News < GPCRs in Oncology and Immunology Blockade of vasoactive intestinal peptide receptor 2 ( progression in MCF-7 cells Published date March 1, 2024 Abstract "Vasoactive intestinal peptide (VIP) receptor 2 (VIPR2) is a G protein-coupled receptor that binds to Gαs, Gαi, and Gαq proteins to regulate various
- Ep 114 with Dr. Robert F. Bruns
doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine receptors postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.
- Ep 150 with Dr GPCR Team
GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and I investigated the effect of lung cancer-related mutations in the GAIN domain of the Latrophilin 3 receptor
- Ep 110 with Dr. G. Aditya Kumar
at Hyderabad, India, where he studied the interaction of membrane cholesterol with the serotonin-1A receptor and its effects on receptor signaling and endocytosis. molecular pharmacology, subcellular trafficking, and membrane biology to better understand how the dynamic receptor
- Ep 70 with Dr. Stephen Ferguson
Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor
- Ep 32 with Dr. Chris Tate
basis of GPCR pharmacology through structure determination of the β1-adrenoceptor and adenosine A2A receptor Structures have been determined by X-ray crystallography of receptors coupled to either mini-Gs or mini-Go , and also by electron cryo-microscopy of receptors coupled to mini G protein bound to βγ subunits. a GPCR bound to a biased agonist and coupled to arrestin and also the first structure of a Class D receptor
- Ep 65 with Dr. Sudarshan Rajagopal
the development of approaches to quantify ligand bias and the identification of beta-arrestin-biased receptors The main focus of his lab’s research is on the mechanisms underlying biased agonism at chemokine receptors The chemokine system is relatively unique in having multiple receptors and multiple ligands that display His group and others have shown that many of these ligands act as biased agonists for the same receptor
- CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
for the Treatment of Inflammatory Diseases Published date April 20, 2023 Abstract " The CC chemokine receptor 6 (CCR6) is a G protein-coupled receptor (GPCR) involved in a wide range of biological processes. Th17 cells express the CCR6 receptor and inflammatory cytokines, including IL-17, IL-21 and IL-22, which This review highlights the potential as a therapeutic target of the CCR6 receptor in numerous diseases
- Ep 107 with Dr. Roger Sunahara
structural and pharmacological bases for hormone-mediated activation of G proteins by G protein-coupled receptors These approaches were invaluable to resolve the crystal structure of the beta2-adrenergic receptor (beta2AR We continue to utilize these data to better understand the basis for receptor-G protein specificity and This is an important perspective in the pursuit of receptor subtype-specific ligands, a major aspect Again, our intention is to target specific receptor subtypes.
- Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway
< GPCR News < GPCRs in Oncology and Immunology Vasoactive intestinal peptide receptor 2 signaling promotes enhancing the ERK pathway Published date January 2, 2023 Abstract “ Vasoactive intestinal peptide (VIP) receptor 2 (VIPR2) is a class B G protein-coupled receptor with the neuropeptide VIP as a ligand.
- Ep 69 with Dr. Stephen Ferguson
Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Structural Determinants Of GAIN Domain Autoproteolysis And Cleavage Resistance Of Adhesion G Protein-Coupled Receptors The GPCR autoproteolysis-inducing (GAIN) domain is a hallmark feature of adhe-sion G-protein coupled receptors We de-termined the crystal structure of the human ADGRB2/BAI2 hormone receptor (HormR) and GAIN domains domains which regulates signaling Sumit Bandekar Abstract "Cadherin EGF Laminin G seven-pass G-type receptors (CELSRs) are conserved adhesion G protein-coupled receptors; they are essential for embryogenesis and
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
, G-CSF, and mitoxantrone in untreated AML Published date September 12, 2023 Abstract "CC chemokine receptor -3 (hCCR3), a G protein-coupled receptor (GPCR) expressed predominantly on eosinophils, is an important This study constructed a nanogold receptor sensor using hCCR3 as the molecular recognition element and This offers a novel approach to quantitatively evaluate chemokine-receptor activation and antagonism
- Flash News / DrGPCR
pharmacological assays, and NMR to reveal the molecular mechanism of biased activation at the vasopressin V2 receptor -%CE%B2-arrestin-recruitment-and-receptor-internalization-in-cxcr1-signalling #gpcr #drgpcr Dec 5, 2024 👅🔬 Researchers have unveiled the cryo-EM structure of TAS2R14 , the most promiscuous bitter taste receptor allosteric modulation with light control, paving the way for new therapeutic strategies targeting muscarinic receptors out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine receptors
- Emerging GPCR targets for AUD: Insights from preclinical studies
for AUD: Insights from preclinical studies Published date July 5, 2024 Abstract "G protein-coupled receptors (GPCRs) are the largest group of membrane receptors in the central nervous system and one of the key Currently, many drugs available on the market act via GPCRs and these receptors remain attractive targets
- G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression
< GPCR News < GPCRs in Oncology and Immunology G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression Published date July 31, 2024 Abstract "G protein-coupled receptors (GPCRs) are
- Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
< GPCR News < GPCRs in Oncology and Immunology Activation of PI3K/Akt pathway by G protein-coupled receptor Among eukaryotes, the G protein-coupled receptor (GPCR) family stands as the largest group of membrane As a member of the GPCR family, G protein-coupled receptor 37 (GPR37) exhibits unknown functions in tumors